JPMorgan Claverhouse (LON:JCH) Shares Cross Above Fifty Day Moving Average - Time to Sell?

Key Points

• JPMorgan Claverhouse shares crossed above its 50-day moving average on Wednesday, trading as high as GBX 888 and last at GBX 884 on a volume of 105,987 shares.
• The trust sits above its 200-day MA (GBX 846.85), has a market cap of £483.67m, a PE ratio of 9.13 and a beta of 0.83, indicating a relatively low-volatility, attractively valued profile.
• Income-focused investment trust: it targets high-quality UK large-cap stocks with the ability to deliver growing dividends and is managed by JPMorgan’s experienced UK equity team.

JPMorgan Claverhouse (LON:JCH - ) shares crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 884.71 and traded as high as GBX 888. JPMorgan Claverhouse shares last traded at GBX 884, with a volume of 105,987 shares changing hands.

JPMorgan Claverhouse Price Performance

The stock has a 50 day moving average of GBX 884.71 and a 200-day moving average of GBX 846.85. The company has a debt-to-equity ratio of 8.94, a quick ratio of 67.67 and a current ratio of 23.01. The company has a market cap of £483.67 million, a PE ratio of 9.13 and a beta of 0.83.

About JPMorgan Claverhouse

Great British dividends The JPMorgan Claverhouse Investment Trust has been helping investors tap directly into the long-term growth potential of UK large cap stocks since 1963. The trust focuses on attractively valued, high quality stocks with the ability to generate consistent and growing dividends. Key points Expertise • Managed by an investment team with long-standing UK equity experience, backed by the extensive resources of J.P. Morgan's global investment platform. Portfolio • Active approach seeks out high quality UK large-cap stocks with the ability to deliver a growing income and long-term capital growth.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.